Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blockade of the angiotensin system improves mental health domain of quality of life: A meta-analysis of randomized clinical trials
Daniel J. Brownstein, Estela Salagre, Cristiano A. Köhler, et al.
Australian & New Zealand Journal of Psychiatry (2017) Vol. 52, Iss. 1, pp. 24-38
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
Lakshmi N. Yatham, Sidney H. Kennedy, Sagar V. Parikh, et al.
Bipolar Disorders (2018) Vol. 20, Iss. 2, pp. 97-170
Open Access | Times Cited: 1394
Call to action regarding the vascular‐bipolar link: A report from the Vascular Task Force of the International Society for Bipolar Disorders
Benjamin I. Goldstein, Bernhard T. Baune, David J. Bond, et al.
Bipolar Disorders (2020) Vol. 22, Iss. 5, pp. 440-460
Open Access | Times Cited: 85
Antihypertensive Drugs and Risk of Depression
Lars Vedel Kessing, Helene C. W. Rytgaard, Claus Thorn Ekstrøm, et al.
Hypertension (2020) Vol. 76, Iss. 4, pp. 1263-1279
Closed Access | Times Cited: 66
Renin-angiotensin system: The underlying mechanisms and promising therapeutical target for depression and anxiety
Sizhu Gong, Fang Deng
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 17
Role of brain renin–angiotensin system in depression: A new perspective
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 17
Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects
Carla Carnovale, Cristiana Perrotta, Sara Baldelli, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 3, pp. 647-667
Open Access | Times Cited: 25
An Open‐Label, Non‐randomized, Drug‐Repurposing Study to Explore the Clinical Effects of Angiotensin II Type 1 (AT1) Receptor Antagonists on Anxiety and Depression in Parkinson's Disease
Sofía Bordet, Lina Grasso, Lucas Udovin, et al.
Movement Disorders Clinical Practice (2025)
Open Access
The association of antihypertensive use and depressive symptoms in a large older population with hypertension living in Australia and the United States: a cross-sectional study
Bruno Agustini, Mohammadreza Mohebbi, Robyn L. Woods, et al.
Journal of Human Hypertension (2020) Vol. 34, Iss. 11, pp. 787-794
Open Access | Times Cited: 33
Cardiovascular therapeutics: A new potential for anxiety treatment?
Kristina Repova, Silvia Aziriova, Kristina Krajcirovicova, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1202-1245
Open Access | Times Cited: 20
Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study
Chiara Fabbri, Siegfried Kasper, Joseph Zohar, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 104, pp. 110050-110050
Closed Access | Times Cited: 26
Onset and recurrence of psychiatric disorders associated with anti-hypertensive drug classes
Lucy Colbourne, Sierra Luciano, Paul J. Harrison
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22
Distinct effects of antihypertensives on depression in the real-world setting: A retrospective cohort study
Yanlin Cao, Xiao Xiang, Jinlin Song, et al.
Journal of Affective Disorders (2019) Vol. 259, pp. 386-391
Closed Access | Times Cited: 24
Targeting the renin angiotensin system for the treatment of anxiety and depression
Sophocles Chrissobolis, Anh Luu, R. Waldschmidt, et al.
Pharmacology Biochemistry and Behavior (2020) Vol. 199, pp. 173063-173063
Closed Access | Times Cited: 22
The relationship between antihypertensive medications and mood disorders: analysis of linked healthcare data for 1.8 million patients
Richard Shaw, Daniel Mackay, Jill P. Pell, et al.
Psychological Medicine (2020) Vol. 51, Iss. 7, pp. 1183-1191
Open Access | Times Cited: 21
Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan
Stefano Omboni, Massimo Volpe
Advances in Therapy (2018) Vol. 36, Iss. 2, pp. 278-297
Open Access | Times Cited: 22
Revisiting the potential of South American rattlesnake Crotalus durissus terrificus toxins as therapeutic, theranostic and/or biotechnological agents
Mirian A.F. Hayashi, Joana D. Campeiro, Camila M. Yonamine
Toxicon (2021) Vol. 206, pp. 1-13
Open Access | Times Cited: 13
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension
Thomas T. van Sloten, Patrick C. Souverein, Coen D.A. Stehouwer, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 5, pp. 594-603
Open Access | Times Cited: 9
Association of depression with mortality in an elderly treated hypertensive population
E. Chowdhury, Michael Berk, Mark Nelson, et al.
International Psychogeriatrics (2018) Vol. 31, Iss. 3, pp. 371-381
Closed Access | Times Cited: 14
Angiotensin I converting enzyme gene polymorphisms and risk of psychiatric disorders
Mohammadarian Akbari, Reyhane Eghtedarian, Bashdar Mahmud Hussen, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Associations of Cardiovascular Agents and Metformin with Depression Symptoms: A Cross-Sectional Analysis from the HUNT Study, Norway
Ivana Bojanić, Ottar Bjerkeset, Lana J. Williams, et al.
Drugs - Real World Outcomes (2022) Vol. 9, Iss. 3, pp. 503-516
Open Access | Times Cited: 5
Use of ACE-inhibitors and Quality of Life in an Older Population
Alice Laudisio, Silvia Giovannini, Panaiotis Finamore, et al.
The journal of nutrition health & aging (2018) Vol. 22, Iss. 10, pp. 1162-1166
Open Access | Times Cited: 7
The effect of combined treatment with SSRIs and renin-angiotensin system (RAS) drugs: A propensity score matched cohort study
Ole Köhler‐Forsberg, Liselotte Petersen, Michael Berk, et al.
European Neuropsychopharmacology (2020) Vol. 32, pp. 120-130
Closed Access | Times Cited: 6
Risk of antidepressant initiation among users of cardiovascular agents and metformin.
Ivana Bojanić, Ottar Bjerkeset, Lana J. Williams, et al.
Pharmacology Research & Perspectives (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 2
The impact of meditation aided by VR technology as an emerging therapeutic to ease cancer related anxiety, stress, and fatigue
D. Michael Franklin, Charles Silvestro, Robert A. Carrillo, et al.
Frontiers in Virtual Reality (2023) Vol. 4
Open Access | Times Cited: 2
Sex-dependent effects of angiotensin II type 1 receptor blocker on molecular and behavioral changes induced by single prolonged stress
Emily Ortiz-Nazario, Carla M. Denton-Ortiz, Lawry D.M. Soto-Escobar, et al.
Behavioural Brain Research (2023) Vol. 454, pp. 114639-114639
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top